CA2207775A1 - Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene - Google Patents

Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene

Info

Publication number
CA2207775A1
CA2207775A1 CA002207775A CA2207775A CA2207775A1 CA 2207775 A1 CA2207775 A1 CA 2207775A1 CA 002207775 A CA002207775 A CA 002207775A CA 2207775 A CA2207775 A CA 2207775A CA 2207775 A1 CA2207775 A1 CA 2207775A1
Authority
CA
Canada
Prior art keywords
blood
oxygen
hemoglobin
rhbl
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002207775A
Other languages
English (en)
Inventor
Michael A. Mccarty
W. Davis Templeton Jr.
Steven A. Shoemaker
Michael J. Gerber
Robert F. Caspari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Somatogen Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2207775A1 publication Critical patent/CA2207775A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02Blood transfusion apparatus

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La présente invention concerne un procédé favorisant le don de sang autologue. Ce procédé consiste à administrer, après prélèvement d'une partie du sang d'un patient, une dose d'hémoglobine acellulaire accroissant l'apport en oxygène. L'invention concerne également un procédé de traitement de la dette d'oxygène par administration d'une dose d'hémoglobine acellulaire accroissant l'apport en oxygène.
CA002207775A 1995-01-13 1996-01-16 Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene Abandoned CA2207775A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US37218695A 1995-01-13 1995-01-13
US08/372,186 1995-01-13
US47752895A 1995-06-07 1995-06-07
US47752995A 1995-06-07 1995-06-07
US08/477,529 1995-06-07
US08/477,528 1995-06-07

Publications (1)

Publication Number Publication Date
CA2207775A1 true CA2207775A1 (fr) 1996-09-19

Family

ID=27409067

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002207775A Abandoned CA2207775A1 (fr) 1995-01-13 1996-01-16 Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene

Country Status (5)

Country Link
EP (1) EP0802805A1 (fr)
JP (1) JPH11501829A (fr)
AU (1) AU4746596A (fr)
CA (1) CA2207775A1 (fr)
WO (1) WO1996028197A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117695460A (zh) * 2023-12-29 2024-03-15 中山大学附属第一医院 一种多功能血液回收装置及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416280A (en) * 1980-04-07 1983-11-22 Minnesota Mining And Manufacturing Company Cardioplegia delivery system
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US4883455A (en) * 1988-09-13 1989-11-28 Minnesota Mining And Manufacturing Company Cardioplegia administration set
US5344393A (en) * 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117695460A (zh) * 2023-12-29 2024-03-15 中山大学附属第一医院 一种多功能血液回收装置及其使用方法
CN117695460B (zh) * 2023-12-29 2024-05-10 中山大学附属第一医院 一种多功能血液回收装置及其使用方法

Also Published As

Publication number Publication date
AU4746596A (en) 1996-10-02
WO1996028197A1 (fr) 1996-09-19
EP0802805A1 (fr) 1997-10-29
JPH11501829A (ja) 1999-02-16

Similar Documents

Publication Publication Date Title
Vlahakes et al. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement
US6007774A (en) Method for the treatment of organ ischemia or infarct comprising hemodilution
Dunn et al. Hemodynamic, metabolic, and hematologic effects of pulsatile cardiopulmonary bypass
US5451205A (en) Facilitated oxygen delivery in conjunction with hemodilution
US5082831A (en) Total body washout solution and method of use
Goodin et al. A perfluorochemical emulsion for prehospital resuscitation of experimental hemorrhagic shock: a prospective, randomized, controlled study
Faithfull Mechanisms and efficacy of fluorochemical oxygen transport and delivery
Niinikoski et al. Oxygen transport to tissue under normovolemic moderate and extreme hemodilution during coronary bypass operation
Engelman et al. High-volume crystalloid cardioplegia: An improved method of myocardial preservation
Takahashi Characterization of neo red cells (NRCs), their function and safety in vivo tests
Dunlap et al. Resuscitation with diaspirin crosslinked hemoglobin in a pig model of hemorrhagic shock
Menasche et al. Limitation of vasodilation associated with warm heart operation by a “mini-cardioplegia” delivery technique
Gould et al. Hypovolemic shock
Mitsuno et al. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan
CA2207775A1 (fr) Procede favorisant le don de sang autologue et permettant le traitement de la dette d'oxygene
Couch et al. Autotransfusion in three variations
Standl Artificial oxygen carriers as red blood cell substitutes–perfluorocarbons and cell-free hemoglobin
Agishi et al. (Pyridoxalated Hemoglobin)-(Polyoxyethylene) Conjugate Solution as Blood Substitute for Normothermic Whole Body Rinse-Out
Watzek et al. Experience with “isovolaemic” haemodilution in extensive surgery for oro-facial tumours
CA2085475A1 (fr) Solutions hyperosmotiques pour reequilibration de la natremie
Parrish et al. Prebypass pheresis and red blood cell exchange in a patient with homozygous SS sickle cell disease undergoing cardiopulmonary bypass: a case report
Rawlings et al. Prolonged perfusion with a membrane oxygenator in awake ponies
WO2000013501A9 (fr) Fluides sanguins artificiels ameliores
Ecker et al. Changes in 2, 3-diphosphoglycerate after cardiopulmonary bypass
RU2195169C2 (ru) Способ восполнения кровопотери

Legal Events

Date Code Title Description
FZDE Dead